GSK Aug 2024 35.000 call
| Previous close | 4.9000 |
| Open | 4.9000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 35.00 |
| Expiry date | 2024-08-16 |
| Day's range | 4.9000 - 4.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Evening StandardFTSE 100 Live 17 May: Land Securities results, GSK nets £1.25bn in final Haleon stake sale
GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results. The sale of GSK’s remaining 4% stake raised £1.25 billion, having held 13% following its 2022 demerger of the Panadol and Sensodyne business. Land Securities revealed a smaller full-year loss of £341 million amid “robust” rental growth across its estate.
BloombergGSK to Sell Remaining $1.6 Billion Stake in Haleon
(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.Most Read from BloombergUS Inflation Data Was Accidentally Released 30 Minutes EarlyWith a BlackRock CEO, $9 Trillion Vanguard Braces for TurbulencePutin and Xi Vow to Step Up Fight to Counter US ‘Containment’Jamie Dimon Sees ‘Lot of Inflationary Forces in Front of Us’Dow Average Touches 40,000 Before Pulling Back: Markets Wra
GuruFocus.comGSK PLC's Dividend Analysis
GSK PLC (NYSE:GSK) recently announced a dividend of $0.38 per share, payable on July 11, 2024, with the ex-dividend date set for May 16, 2024. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Utilizing the data from GuruFocus, let's delve into GSK PLC's dividend performance and assess its sustainability.
